In addition, in patients with resected squamous cell lung carcinoma, PD-L2 expression on tumor cells at two different cuts-off (> 5% and > 10% positive cells) predicted better outcomes. The gene discussed is PDCD1LG2; the disease is squamous cell lung carcinoma.